A detailed history of Private Advisor Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 1,767 shares of CRL stock, worth $345,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,767
Previous 1,978 10.67%
Holding current value
$345,925
Previous $408,000 14.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$187.96 - $245.29 $39,659 - $51,756
-211 Reduced 10.67%
1,767 $348,000
Q2 2024

Aug 05, 2024

BUY
$206.39 - $268.73 $56,344 - $73,363
273 Added 16.01%
1,978 $408,000
Q1 2024

Apr 30, 2024

BUY
$203.52 - $273.43 $4,680 - $6,288
23 Added 1.37%
1,705 $461,000
Q4 2023

Feb 06, 2024

BUY
$164.52 - $238.84 $276,722 - $401,728
1,682 New
1,682 $397,000
Q2 2022

Jul 13, 2022

BUY
$204.13 - $302.4 $7,961 - $11,793
39 Added 2.93%
1,370 $293,000
Q1 2022

May 12, 2022

BUY
$255.51 - $362.11 $45,480 - $64,455
178 Added 15.44%
1,331 $378,000
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $5.54 Million - $7.08 Million
-15,780 Reduced 93.19%
1,153 $434,000
Q3 2021

Oct 14, 2021

BUY
$372.64 - $458.3 $2.94 Million - $3.61 Million
7,878 Added 87.0%
16,933 $6.99 Million
Q2 2021

Aug 12, 2021

BUY
$294.17 - $371.65 $163,852 - $207,009
557 Added 6.55%
9,055 $3.35 Million
Q1 2021

Apr 22, 2021

SELL
$249.67 - $299.48 $285,372 - $342,305
-1,143 Reduced 11.86%
8,498 $2.46 Million
Q4 2020

Apr 01, 2021

BUY
$222.0 - $252.62 $2.14 Million - $2.44 Million
9,641 New
9,641 $2.41 Million
Q3 2020

Nov 02, 2020

SELL
$175.56 - $226.45 $44,943 - $57,971
-256 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$118.84 - $189.72 $30,423 - $48,568
256 New
256 $45,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.